Thursday, February 21, 2019

San Diego, California

A number of Parkinson’s disease support groups in the San Diego area have offered us an opportunity to present to their members. The
exact location and time of the presentation are being clarified and we should have specific information in our January 2019 Monthly Update. 


To RSVP for this event email: vika@zhittyamedicine.com or complete the RSVP below and click submit.  Please indicate which location you would like to attend. Thank you

Wednesday, February 6, 2019: 

New Port Richey, Florida at 1:00 PM

A presentation is being hosted by the New Port Richey Parkinson’s Disease Support Group and the Family Fitness Centers of Pasco. The presentation will be at the Timber Greens Country Club, 6333 Timber Greens Blvd., New Port Richey, Florida. Similar to the talk at St. Simons Island, the presentation will focus on Zhittya’s hypothesis on the cause of neurodegenerative diseases, including Parkinson’s disease, ALS (Lou Gehrig’s disease), Alzheimer’s disease, Multiple Sclerosis, stroke recovery and more. Zhittya will also discuss its novel biological drug to treat these diseases and the timeframe for the start of FDA-authorized clinical trials in subjects with Parkinson’s disease, ALS, multiple systems atrophy (MSA) and Alzheimer’s Disease. 


To RSVP for this event email: vika@zhittyamedicine.com or complete the RSVP below and click submit.  Please indicate which location you would like to attend. Thank you

Event Schedule

diseases, including Parkinson’s disease, ALS (Lou Gehrig disease), Alzheimer’s disease, Multiple Sclerosis, stroke recovery and more. Zhittya will also discuss its novel biological drug to treat these diseases and the timeframe for the start of FDA-authorized
clinical trials in subjects with Parkinson’s disease, ALS, multiple systems atrophy (MSA) and Alzheimer’s Disease. 


To RSVP for this event email: vika@zhittyamedicine.com or complete the RSVP below and click submit.  Please indicate which location you would like to attend. Thank you

By March 2019, we hope to have FDA responses to our proposed clinical trials for Parkinson’s disease and ALS and to have initiated screening of candidates for those trials. Based on the FDA response to the above two clinical trials, the plan is to proceed with additional FDA submissions to treat Alzheimer’s disease, multiple sclerosis, and stroke recovery.


We are exploring giving additional presentations to Parkinson’s disease and ALS support groups in Huntsville, Alabama and would consider additional presentations in nearby cities (for example Atlanta, Birmingham or Nashville). If you have any relationship with Parkinson’s disease groups in the South, please let us know. We are open to giving presentations and spreading the word!


As we state in our presentations, we believe the “primary objective” of our followers is not that they are selected to participate in our first trial, but that we succeed and that there is a treatment for Parkinson’s disease and ALS as soon as possible. We anticipate doing many clinical trials to find the safest and most efficacious dose of our drug to give the best medical outcomes. We know time delays are not a friend of Parkinson’s disease or ALS sufferers and we are committed to going as fast as we can. We strive through our presentations to educate people on what we are doing, why we believe our drug works, so we will have subjects with an “informed mind” choosing to participate in our clinical trials. 


Lastly, someone asked us: “Why would we go to Huntsville, Alabama to present?” The answer – the same reason we went to Mesa, Arizona; Cedar City, Utah; St. George Utah and Palm Springs, California. The same reason we are going to St. Simon’s Island Georgia and New Port Richey, Florida:

Because someone asked us to come there!

To R.S.V.P to any of our Presentations, Please complete the form with your request and we will be sure to get you on the list.

Other Possible Future Presentations

Developing healthier lives for the world


For more information contact us today.

Tuesday, February 5, 2019: 

St. Simons Island, Georgia

Two presentations will be given at the Centered for Life, located at 2487 Demere Rd., #500, Saint Simons Island, Georgia.


The first presentation will be given at 12 noon and a second presentation at 7 pm (EST). If you RSVP, please tell us which time you prefer. The two presentations will be the same, just at different times for people to choose.


This event is hosted by the Centered for Life organization. The presentation will focus on Zhittya’s hypothesis on the cause of neurodegenerative

Thursday, February 7 through Sunday, February 10, 2019

MoneyShow Orlando, Florida

The annual MoneyShow Orlando will be held at the Omni Orlando Resort at Champions Gate, Orlando, FL. This event is expecting around 4,500 investor attendees. Zhittya will have an exhibition booth (#310) at this conference from Thursday, February 7, 6:30 PM through Saturday, February 9, 6:00 PM. 


Dr. Jacobs and Dan Montano will be available at the exhibit booth to meet and answer questions from attendees. 


*NOTE: CHANGE OF DATE FOR VIP BREAKFAST PRESENTATION FROM SATURDAY, FEBRUARY 9th
TO FRIDAY, FEBRUARY 8th AT 7 am
 


The VIP breakfast presentation at the Orlando MoneyShow has received such an overwhelming response that we needed to get a larger room
for people interested in attending it. The VIP Breakfast Presentation has now been moved from its originally scheduled Saturday date forward one day to Friday morning, February 8th
at 7 am. 


For those of you who have already confirmed and RSVP to us for tickets, please reconfirm that you will still be able to attend the breakfast on Friday morning. We have people who we know are flying to the meeting from Boston, Germany, and Kuwait and I hope the change of date of our breakfast conference is not a problem for you. 


If it is, perhaps we can try and figure out how to accommodate you. Maybe we can have a breakfast meeting and presentation Saturday morning with Dr. Jacobs at the hotel? Please see below for more information on this breakfast meeting. 

Friday, February 8, 2019, at 7:00 AM

MoneyShow’s VIP Breakfast for its Alumni members (hosted by WUND Healing Biopharmaceuticals and Zhittya)

At this breakfast conference, Dr. Jacobs and Dan Montano will present an overview of Zhittya’s drug development efforts. 


In addition, Mr. John Laub, CEO of WUND Healing Biopharmaceuticals (WUND), will discuss his company’s business responsibilities, which include the sale and distribution of Zhittya’s portfolio of drugs, including the drug being developed for the treatment of Parkinson’s disease and other neurodegenerative diseases. 
Tickets for the breakfast event are free, but you must make a reservation and obtain an Admittance Ticket.


The MoneyShow is keeping many tickets for their VIP Investor Members and Zhittya is holding a limited amount of tickets for our guests to the event. As of November 30, the analytics of our Google campaign for Parkinson’s disease indicates that in the first 11 months of this year we have enjoyed in excess of over 215,000 clicks to our Zhittya sites on Parkinson’s disease. The analytics also indicate that around 22% of those people come from Florida, the Carolinas, Georgia, and Alabama, all states within easy driving distance to Orlando. We recognize that a small percentage of those people are investor-types interested in attending the MoneyShow, however, if you are interested in attending the breakfast presentation, please RSVP and request an Admittance Ticket from us as soon as possible. Of the tickets Zhittya is holding for its invitees, most have been taken already, and we are still two months away from the event.


If you wish to obtain tickets for the breakfast presentation please email: 
Vika Montano at vika@zhittyamedicine.com or complete the RSVP below and click submit.  Please indicate which location you would like to attend. Thank you


We encourage you to visit us at the MoneyShow Orlando. Attendance is free if you register with the MoneyShow as an investor. If you want to register and attend this Florida conference, please email us and we will send you the necessary information.


Diabetes, Insufficient blood perfusion, diabetic foot ulcers, cardiovascular disease, peripheral artery disease, stroke, clinical development, formulations of FGF-1, medical indications, active drug development programs, vascular disorders in the brain, vascular disorders feet, vascular disorders heart, Regeneration of new blood vessels via angiogenesis, Regeneration of new blood, angiogenesis, blood vessels in the body, growth factors, stimulate new vessel growth, Insufficient blood perfusion, peripheral artery disease, stroke, therapeutic angiogenesis, unnecessary amputations, Perfusion, cardiovascular health, optimal perfusion. Ischemia, blood flow interrupted, coronary arteries, coronary artery disease, myocardial ischemia, Chest pain, angina, myocardial cells, prolonged ischemia, prolonged ischemia of heart tissue, necrosis, poor circulation, and oxygen-starved hearts, therapeutic angiogenesis, Fibroblast growth factor 1 (FGF-1) potent angiogenic agent, Fibroblast growth factor, growth factors, stimulate angiogenesis, production capillaries, production capillaries arterioles, FGF cell surface receptor, Diabetic foot ulcers, Venous leg ulcers, Stroke, Vascular Dementia, multi-infarct dementia, lack of blood perfusion results, blood brain barrier, IV infusions, Alzheimer’s Disease, degeneration in the microvasculature of the brain, neurofibrillary tangles, Coronary Artery Disease, Dan Montano, Zhittya Regenerative Medicine, life-saving drugs, Jack Jacobs, Ph.D., President and Chief Scientific Officer, Davidson College, Washington University, St. Louis,Viktoriya Tamlenova-Montano, Vice President of Strategic Innovation, heavy industry detailing and construction from Kiev College of Electric Engineering, Construction and Industrial Design Kiev State University of Civil Engineering and Architecture, Kiev State University of Civil Engineering and Architecture, Canada, South East Asia, Latin America, China, India, Korea, Japan, South-East Asia, India, Korea, Japan and Australia, New Zealand, Las Vegas, Las Vegas Nevada, biotechnology, biopharmaceuticals, wound healing biotherapeutics, wound healing
Diabetes, Insufficient blood perfusion, diabetic foot ulcers, cardiovascular disease, peripheral artery disease, stroke, clinical development, formulations of FGF-1, medical indications, active drug development programs, vascular disorders in the brain, vascular disorders feet, vascular disorders heart, Regeneration of new blood vessels via angiogenesis, Regeneration of new blood, angiogenesis, blood vessels in the body, growth factors, stimulate new vessel growth, Insufficient blood perfusion, peripheral artery disease, stroke, therapeutic angiogenesis, unnecessary amputations, Perfusion, cardiovascular health, optimal perfusion. Ischemia, blood flow interrupted, coronary arteries, coronary artery disease, myocardial ischemia, Chest pain, angina, myocardial cells, prolonged ischemia, prolonged ischemia of heart tissue, necrosis, poor circulation, and oxygen-starved hearts, therapeutic angiogenesis, Fibroblast growth factor 1 (FGF-1) potent angiogenic agent, Fibroblast growth factor, growth factors, stimulate angiogenesis, production capillaries, production capillaries arterioles, FGF cell surface receptor, Diabetic foot ulcers, Venous leg ulcers, Stroke, Vascular Dementia, multi-infarct dementia, lack of blood perfusion results, blood brain barrier, IV infusions, Alzheimer’s Disease, degeneration in the microvasculature of the brain, neurofibrillary tangles, Coronary Artery Disease, Dan Montano, Zhittya Regenerative Medicine, life-saving drugs, Jack Jacobs, Ph.D., President and Chief Scientific Officer, Davidson College, Washington University, St. Louis,Viktoriya Tamlenova-Montano, Vice President of Strategic Innovation, heavy industry detailing and construction from Kiev College of Electric Engineering, Construction and Industrial Design Kiev State University of Civil Engineering and Architecture, Kiev State University of Civil Engineering and Architecture, Canada, South East Asia, Latin America, China, India, Korea, Japan, South-East Asia, India, Korea, Japan and Australia, New Zealand, Las Vegas, Las Vegas Nevada, biotechnology, biopharmaceuticals, wound healing biotherapeutics, wound healing